Gamifant.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Gamifant® (emapalumab-lzsg) | For Healthcare Professionals |
| Description | The first & only FDA-approved treatment for primary hemophagocytic lymphohistiocytosis (HLH) specifically designed to target and neutralize interferon gamma. |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 184.106.55.135 |
| Location | New York, New York, United States |
Related Websites
| Site | Rank |
More to Explore
Gamifant.com Valuation
|
US$20,258
Last updated: Jun 21, 2020
Gamifant.com has global traffic rank of 1,685,844. Gamifant.com has an estimated worth of US$ 20,258, based on its estimated Ads revenue. Gamifant.com receives approximately 1,850 unique visitors each day. Its web server is located in New York, New York, United States, with IP address 184.106.55.135. According to SiteAdvisor, gamifant.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$20,258 |
| Daily Ads Revenue | US$11 |
| Monthly Ads Revenue | US$333 |
| Yearly Ads Revenue | US$4,051 |
| Daily Unique Visitors | 1,850 |
| Note: All traffic and earnings values are estimates. | |
Traffic Ranks
| Global Rank | 1,685,844 |
| Delta (90 Days) | 0 |
| Most Popular In Country | N/A |
| Country Rank | N/A |
DNS Records
| Host | Type | TTL | Data |
| gamifant.com | A | 7199 | IP: 184.106.55.135 |
| gamifant.com | NS | 7199 | Target: dns03.ports.se. |
| gamifant.com | NS | 7199 | Target: dns.biovitrum.com. |
| gamifant.com | SOA | 7199 | MNAME: dns.biovitrum.com. RNAME: postmaster.sobi.com. Serial: 2020021704 Refresh: 3600 Retry: 1799 Expire: 604800 Minimum TTL: 7200 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Apache/2.4 Content-Type: text/html; charset=iso-8859-1 Date: Sun, 21 Jun 2020 04:30:14 GMT Location: https://www.gamifant.com/ Connection: Keep-Alive Set-Cookie: X-Mapping-knikccmo=BC018885C7CDDA18979DC7EC92CC35D9; path=/ Content-Length: 299 HTTP/1.1 200 OK server: Apache/2.4 vary: Accept-Encoding,User-Agent content-type: text/html; charset=UTF-8 date: Sun, 21 Jun 2020 04:30:14 GMT transfer-encoding: chunked set-cookie: X-Mapping-knikccmo=6C87D404C86397675DC7F0383AD938FD; path=/ |
Gamifant.com Whois Information
Domain Name: GAMIFANT.COM Registry Domain ID: 1958349764_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domaininfo.com Registrar URL: http://www.ports.domains Updated Date: 2018-12-11T07:23:49Z Creation Date: 2015-09-08T08:46:00Z Registry Expiry Date: 2021-09-08T08:46:00Z Registrar: Ports Group AB Registrar IANA ID: 73 Registrar Abuse Contact Email: abuse@portsgroup.se Registrar Abuse Contact Phone: +46.707260017 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS.BIOVITRUM.COM Name Server: DNS03.PORTS.SE DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: gamifant.com Registry Domain ID: 1958349764_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domaininfo.com Registrar URL: ports.domains Updated Date: 2018-12-11T07:23:49Z Creation Date: 2015-09-08T08:46:00Z Registrar Registration Expiration Date: 2021-09-08T08:46:00Z Registrar: PortsGroup AB Registrar IANA ID: 73 Registrar Abuse Contact Email: abuse@portsgroup.se Registrar Abuse Contact Phone: +46.317202000 Registrant Organization: Novimmune SA Registrant State/Province: Registrant Country: SE Name Server: dns.biovitrum.com Name Server: dns03.ports.se DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net ---------------------------------------------------------------------------- You agree that you will not reproduce, sell, transfer, or modify any of the data presented in response to your search request, or use of any such data for commercial purpose, without the prior express written permission of Domaininfo AB - domaininfo.com Register your name in 200+ top level domains at http://www.domaininfo.com domaininfo.com ---------------------------------------------------------------------------- |